tiprankstipranks

Neal Walker Insider Profile

4 Followers
Neal Walker, Director at Aldeyra Therapeutics, holds 1.38M shares in Aclaris Therapeutics (Ticker: ACRS), holds 15.85K shares in Aldeyra Therapeutics (Ticker: ALDX).
tipranks
Neal Walker

Neal Walker
Aldeyra Therapeutics (ALDX)
Director

Ranked #31,741 out of 99,335 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+13.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
98.73%
1.27%
A breakdown of Neal Walker's holdings

Insider Roles

Aclaris Therapeutics
(ACRS)
INTERIM PRESIDENT AND CEO, Director
Aldeyra Therapeutics
(ALDX)
Director
Roles that Neal Walker holds in companies

Most Profitable Insider Trade

Stock:
Aclaris Therapeutics
(ACRS)
Rating:Informative Sell
Date:Mar 14, 2022 - Mar 14, 2023
Return:+43.40%
The most profitable trade made by Neal Walker

Neal Walker's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aldeyra Therapeutics
Aug 24, 2023
Director
Uninformative Buy
5.28K
$76.26K
Aclaris Therapeutics
Nov 05, 2024
INTERIM PRESIDENT AND CEO, Director
Uninformative Buy
14.10K
$5.95M
List of latest transactions for each holding click on a transaction to see Neal Walker's performance on stock

Neal Walker insider profile FAQ

What is the percentage of profitable transactions made by Neal Walker?
The percentage of profitable transactions made by Neal Walker is 67%.
    What is the average return per transaction made by Neal Walker?
    The average return per transaction made by Neal Walker is 13.00%.
      What stocks does Neal Walker hold?
      Neal Walker holds: ALDX, ACRS stocks.
        What was Neal Walker’s latest transaction?
        Neal Walker latest transaction was an Uninformative Buy of $14.10K.
          What was Neal Walker's most profitable transaction?
          Neal Walker’s most profitable transaction was an Informative Sell of ACRS stock on March 14, 2022. The return on the trade was 43.40%.
            What is Neal Walker's role in Aldeyra Therapeutics?
            Neal Walker's role in Aldeyra Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.